Mannatech (NASDAQ:MTEX) Share Price Crosses Below 200 Day Moving Average – Here’s What Happened

Mannatech, Incorporated (NASDAQ:MTEX)’s share price crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $7.10 and traded as low as $5.40. Mannatech shares last traded at $5.71, with a volume of 9,832 shares changing hands.

Analyst Ratings Changes

Separately, Weiss Ratings raised shares of Mannatech from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, Mannatech has a consensus rating of “Sell”.

Mannatech Trading Down 0.2%

The company has a market cap of $11.00 million, a price-to-earnings ratio of -0.85 and a beta of 0.61. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.59 and a current ratio of 1.09. The business’s 50 day moving average price is $5.37 and its 200-day moving average price is $7.09.

Mannatech (NASDAQ:MTEX) last announced its quarterly earnings data on Thursday, May 14th. The company reported $0.49 earnings per share (EPS) for the quarter. Mannatech had a negative net margin of 11.97% and a negative return on equity of 2,383.34%. The company had revenue of $24.92 million during the quarter.

Insider Activity

In other Mannatech news, Director Kevin Andrew Robbins acquired 7,100 shares of the company’s stock in a transaction dated Tuesday, May 19th. The stock was bought at an average price of $4.17 per share, for a total transaction of $29,607.00. Following the purchase, the director owned 33,333 shares in the company, valued at $138,998.61. This represents a 27.07% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. In the last ninety days, insiders have acquired 14,903 shares of company stock valued at $62,155. Corporate insiders own 41.50% of the company’s stock.

Mannatech Company Profile

Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.

The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.